Bio Pharma

The science, scale-up and economics reshaping biologics and advanced therapies.

BiomédicamentsThérapie cellulaire et géniqueCMCMontée en échelle

Every Company Announced Fill-Finish Capacity: Still Scarce?

Everyone announced more fill-finish capacity, so why is it still one of biopharma's tightest bottlenecks? Here's the gap between announcement and reality.

Simantini Singh Deo · 28 août 2026

Article

Why Oral GLP-1 Manufacturing Capacity Decides The Leader

Behind every oral GLP-1 approval is a manufacturing story, here's why factory capacity, not trial data, could decide who leads this market.

Simantini Singh Deo · 26 août 2026